Nurix Therapeutics Executive Disposes of Equity Stake Under Pre-Arranged Plan
Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX), executed a sale of company equity totaling $259,366 on July 2, 2026. The transaction was conducted under a Rule 10b5-1 trading plan. The sale occurs as the stock trades near a 52-week high of $24.88, following a 93% gain over the past year. According to InvestingPro anal…